10x Genomics: Lower Cost Innovation May Drive A Rebound
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...
Seeking Alpha3d
TXG 10x Genomics, Inc.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...
Morningstar3d
10x Genomics Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Yahoo Finance2d
10x Genomics, Inc. (TXG)
After hours: March 21 at 7:53:55 PM EDT Loading Chart for TXG ...
These 10 biotech companies are changing how we discover new drugs and treat complex diseases
The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments ...
Cathie Wood’s ARK buys IRDM stock, sells META and PATH
Cathie Wood’s ARK ETFs have published their daily trades for Wednesday, March 19th 2025, with a series of buys and sells across a range of innovative companies. Leading the purchases was a significant ...